CBRS (CBRS) Stock Price & Analysis

CBRS (CBRS) fell 9.49% to USD 199.12 as of July 25, 2026 at 02:24 UTC, according to Nexqual real-time market data.

CBRS last closed at USD 220; the session ranged USD 192.87–214.98 on volume of 5,927,201 shares. Market capitalization is $44.37B, with a 52-week range of USD 160.81–386.34 (NMS). Source: Nexqual, July 25, 2026 at 02:24 UTC.

Key Statistics (as of July 25, 2026 at 02:24 UTC)

PriceUSD 199.12
Change▼ 9.49% (down)
Previous CloseUSD 220
OpenUSD 213.22
Day RangeUSD 192.87 – 214.98
52-Week RangeUSD 160.81 – 386.34
Volume5,927,201 shares
Market Cap$44.37B
ExchangeNMS

Technical Analysis (CBRS)

Nexqual's technical model rates CBRS "NEUTRAL" based on 1 bullish and 2 bearish signals across 49 daily candles, as of July 25, 2026 at 02:24 UTC.

Overall SignalNEUTRAL
RSI (14)50.08 (neutral)
MACD-6.08 (negative)

Analyst Ratings (CBRS)

Wall Street analysts rate CBRS "Strong Buy" based on 11 analysts, with a mean price target of USD 291.09 (range USD 209–340), per Nexqual as of July 25, 2026 at 02:24 UTC.

Consensus RatingStrong Buy
Analyst Count11
Mean TargetUSD 291.09
High TargetUSD 340
Low TargetUSD 209
Buy / Hold / Sell10 / 1 / 0

Earnings (CBRS)

Next Earnings Date2026-08-12
EPS EstimateUSD -0.18
Revenue Estimate$193.55M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.04 vs est -0.15 ▲ beat

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financials & Fundamentals (CBRS)

Total Revenue$603.88M
Revenue Growth (YoY)+94.40%
Gross Margin+40.35%
Operating Margin-7.78%
Profit Margin+41.02%
ROE+18.79%
Debt / Equity49.47
Current Ratio2.51
Total Cash$2.23B
Total Debt$1.36B

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Financial Health Score (CBRS)

Nexqual rates CBRS's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 02:24 UTC.

GrowthStrong — Revenue +94% YoY (latest Q)
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetStrong — $2.23B cash vs $1.36B debt, net cash position
Cash FlowSolid — Operating cash flow $57M
EfficiencySolid — ROE 19%

Ownership (CBRS)

Insider Ownership+0.14%
Institutional Ownership+40.04%
Shares Outstanding92.13M
Float80.45M
Short % of Float+14.69%

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Leadership (CBRS)

CBRS is led by Andrew D. Feldman (age 55), Co-Founder, CEO, President & Chairman, per Nexqual as of July 25, 2026 at 02:24 UTC.

Co-Founder, CEO, President & ChairmanAndrew D. Feldman (age 55)
Co-Founder & CTOSean Lie (age 45)
Chief Operating OfficerDhiraj Mallick (age 52)
CTO, Emeritus & Co-FounderGary Lauterbach
Senior VP, CFO & TreasurerRobert Patrick Komin (age 62)

Major Backers & Investors (CBRS)

Notable institutional backers of CBRS include Fidelity, AMERICAN FUNDS INSURANCE SERIES-Growth Fund, Washington University, according to Nexqual as of July 25, 2026 at 02:24 UTC.

Active Investors

InvestorStake
Fidelity2.64%
AMERICAN FUNDS INSURANCE SERIES-Growth Fund2.43%
Washington University0.6%
ARK Invest0.56%
Legal Advantage Investments, Inc.0.34%
Hamilton Lane Advisors Llc0.26%
Capital Group0.19%

Index Funds (Passive)

FundStake
State Street0.33%
BlackRock0.32%

Source: Nexqual, July 25, 2026 at 02:24 UTC.

Peers & Related Stocks

SymbolNamePriceChange
SKHYSK hynix Inc.USD 154.57▼ 6.47%
CRWVCoreWeave, Inc.USD 71.88▼ 13.02%
NBISNebius Group N.V.USD 187.77▼ 13.93%
ALABAstera Labs, Inc.USD 291.58▼ 11.88%
CRDOCredo Technology Group Holding USD 213.15▼ 6.62%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:24 UTC. This page is informational and not investment advice.